Ernexa Therapeutics Inc. (ERNA)
Nasdaq • ERNA • US1140824079
ORTEX Data Highlights
ORTEX Data Highlights
As of Oct 27, 2026, ORTEX estimated 2% of free float sold short, 0.4 days to cover, cost to borrow 23.65%. Sign up for live short interest data.
Market Cap
3.15m USD | # 12412 in US
Volume
45.66k shares | 148.33k USD
Shares Outstanding
1.63m
Free Float Shares
74.60% | 1.22m
